Clinical implementation of bempedoic acid in blood lipid management: Real-world data from an Italian lipid clinic
BA was effective and well tolerated in this high-risk cohort, including statin-intolerant and FH patients. Beyond its initial indication, BA now represents a valuable therapeutic option to optimize LDL-cholesterol lowering in patients who remain above target despite standard LLT.
Authors
- Giuliana Mombelli (ORCID: https://orcid.org/0000-0003-2886-134X)
- Cesare R. Sirtori (ORCID: https://orcid.org/0000-0001-6224-5538)
- Chiara Pavanello (ORCID: https://orcid.org/0000-0001-5892-9857)
- Caterina Santolamazza
- Laura Calabresi (ORCID: https://orcid.org/0000-0001-5042-9532)
- Sofia Castiglione
- Antonia Albertí
- Giulia Cincotto
Institutions
- AOL (United States) (US)
- NTT (Italy) (IT)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
Publication Details
- Journal
- Journal of clinical lipidology
- Published
- 2025-09-27
- DOI
- https://doi.org/10.1016/j.jacl.2025.09.033
- Citations
- 1
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Pfizer